A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Yasuhiro Takeshima, Е. Д. Белоусова et al.|Neuromuscular Disorders|2017Cited by 128